Financiado en parte por Almond Board of California
Daily almond consumption in cardiovascular disease prevention via LDL-C change in the U.S. population: a cost-effectiveness analysis
Wang J, Lee Bravatti MA, Johnson EJ, Raman G
BMC public health · 6 citas
Etiquetas de revisión
Vínculos de autores con la industriaFinanciado por la industriaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Eventos clínicos como enfermedad o muerte
- Consumo medido con
- No se indica
Quién lo pagó
- Financiación
- Financiado por la industria
- Gobierno
- U.S. Department of Agriculture
- Grupo de la industria
- Almond Board of California
- Autores
- Al menos un autor declara un vínculo económico con la industria
- Subvenciones
- U.S. Department of Agriculture (58-1950-4-003)
Según 2 financiadores declarados y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2020-04-25 · BMC Public Health · vol. 20 · número 1 · pág. 558
- Editorial
- BioMed Central
- Citado
- 17 citas · más que el 81% de estudios similares · 1.4× el promedio de su campo
- Referencias
- 41 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Nuts composition and effects · Health Systems, Economic Evaluations, Quality of Life · Nutritional Studies and Diet
- Palabras clave
- almond consumption, cardiovascular disease prevention, LDL cholesterol, cost-effectiveness, nut intake, acute myocardial infarction, stroke, quality-adjusted life years, net monetary benefit, dietary intervention
- MeSH
- humans, cardiovascular diseases, diet, adult, cost-benefit analysis, health expenditures, united states, female, male, cholesterol, ldl, prunus dulcis
4 autores
- Jifan Wang🇺🇸 · autor de correspondenciaTufts University
- Michelle A. Lee Bravatti🇺🇸Tufts University
- Elizabeth J. Johnson🇺🇸Tufts University
- Gowri Raman🇺🇸Tufts Medical Center
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Heart disease is the leading cause of death in the United States. The U.S. Food and Drug Administration approved the health claim that 1.5 oz (42.5 g) of nut intake may reduce the risk of cardiovascular disease. Previous studies have focused on the cost-effectiveness of other foods or dietary factors on primary cardiovascular disease prevention, yet not in almond consumption. This study aimed to examine the cost-effectiveness of almond consumption in cardiovascular disease primary prevention.
Perspective & setting
This study assessed the cost-effectiveness of consuming 42.5 g of almond from the U.S. healthcare sector perspective.
Methods
A decision model was developed for 42.5 g of almond per day versus no almond consumption and cardiovascular disease in the U.S.
Population
Parameters in the model were derived from the literature, which included the probabilities of increasing low-density lipoprotein cholesterol, developing acute myocardial infarction and stroke, treating acute myocardial infarction, dying from the disease and surgery, as well as the costs of the disease and procedures in the U.S. population, and the quality-adjusted life years. The cost of almonds was based on the current price in the U.S. market. Sensitivity analyses were conducted for different levels of willingness-to-pay, the probabilistic sensitivity analysis, ten-year risk prevention, different costs of procedures and almond prices, and patients with or without cardiovascular disease.
Results
The almond strategy had $363 lower cost and 0.02 higher quality-adjusted life years gain compared to the non-almond strategy in the base-case model. The annual net monetary benefit of almond consumption was $1421 higher per person than no almond consumption, when the willingness to pay threshold was set at $50,000 for annual health care expenditure. Almond was more cost-effective than non-almond in cardiovascular disease prevention in all the sensitivity analyses.
Conclusion
Consuming 42.5 g of almonds per day is a cost-effective approach to prevent cardiovascular disease in the short term and potentially in the long term.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.